INTRODUCTION
The multilayered epidermis of mammalian skin represents the first protective barrier towards environment. When the two main barrier functions against transepidermal water loss (TEWL) and pathogen invasion become deficient, such as in ichthyosis, atopic dermatitis and psoriasis, specific, indispensable barrier components of the cornified epidermal layer, particularly the cornified envelope (CE) and the extracellular lipid lamellae (ELL), are severely altered. Intracellularly, lipid precursors of the ELL are packed into membrane-limited, tubulovesicular lamellar bodies (LBs) during keratinocyte maturation together with a variety of proteins, including hydrolytic enzymes and antimicrobial peptides. LBs are preferentially extruded at the interface between the viable and anuclear epidermal layers, i.e. the stratum granulosum (SG) and the stratum corneum (SC), respectively. A key regulator of this secretory process is an extracellular calcium gradient (1, 2) .
Alignment of LB content into mature ELL requires sequential extracellular processing of lipid precursors, glucosylceramides (GlcCers) and phospholipids, and establishment of the cornified lipid envelope (CLE), a lipid monolayer covalently bound to the CE and crucial for the competence of the water permeability barrier (WPB). ELL contain high levels of Cers with ultra-long-chain (ULC) (C28 -C36) omega-hydroxylated acyl moieties (abbreviated here as vh-Cers) (1) , which are to a † These authors contributed equally to this work and are listed in alphabetical order. * To whom correspondence should be addressed at: DKFZ-G131, INF 280, 69120 Heidelberg, Germany. Tel: +49 6221424358; Fax: +49 6221424352; Email: r.sandhoff@dkfz.de great extent v-esterified either to fatty acids (FAs), predominantly linoleic acid or to carboxylic acid moities of cross-linked CE proteins forming the CLE. During terminal cornification, vh-Cers are degraded to yield the corresponding FAs and sphingosine (3) . Importantly, the latter has been shown to have anti-microbial activity in vitro (4 -7). Details of vh-Cer biosynthesis and their intracellular transport as well as the biogenesis and secretion of LBs are incompletely understood at a molecular level. However, definite knowledge of these processes and their regulation is of fundamental importance for understanding skin pathophysiology, a prerequisite for targeted therapy.
The biodiversity of Cer species arising in human SC from 12 subclasses (8) requires a family of genes, the CERS family (Cers1 -6 in mammals) (9) . Depending on the substrate specifity towards the length of the acyl-CoAs and the degree of saturation, each of these enzymes synthesizes a subset of Cer species. Whereas CerS have been identified for the incorporation of long-chain (LC, C16 -20) and very long-chain (VLC, C22-26) acyl moieties (10), a distinct member for ULC-acyl CoA substrates (.C26) remains elusive.
The prominent coexpression of CerS3 and of ULCsphingolipids (ULC-SLs) in skin and testis suggested CerS3 in the biosynthesis of vh-Cers in the epidermis (11 -13) . Here, we show by expressing CerS3 in yeast and human cell cultures and by analyzing the epidermal lipids of CerS2-and CerS3-deficient mice that CerS3 function cannot be replaced by one of the other five CerS. Evidence is provided that CerS3-deficient mice lack all SLs with ULC-FAs resulting in WPB disruption, and that mutant skin enables pathogen invasion (Candida albicans). We demonstrate absence of vh-Cers to trigger an epidermal maturation arrest at an embryonic pre-barrier stage. Hallmarks of CerS3 mutant mouse skin include discontinuity of ELL, impairment of CLE as shown with unmasked loricrin, hyperkeratosis, persistence of periderm and non-peripheral corneodesmosomes (CDs) and defective profilaggrin processing. Our data demonstrate ULC-Cers to be engaged in cornification and apoptosis of peridermal cells.
RESULTS

Ultra-long-chain FAs are bona fide substrates of CerS3
From CerS1 -6, only CerS2 and CerS3 accept VLC acyl-CoAs (C22-C26) for the (dihydro-)Cer synthesis (11) . To prove our hypothesis CerS3 to be needed for ULC-Cer production, a non-radioactive and detergent-free enzymatic assay with a range of FAs including ULC-FA montanic acid (28:0), were performed in living HeLa cells and yeast expressing CerS2 or CerS3. In HeLa cells, mCerS3-enhanced green fluorescent protein (EGFP) localized to the endoplasmic reticulum (ER), but not to the Golgi or lysosomes (Fig. 1A 1 -3 ). This expression is in line with the described acylation of sphingoid bases at the ER (10) .
Endogenously, HeLa cells express all Cers mRNAs except for Cers3 mRNA. The major transcripts were those of Cers2, consistent with the main Cer species containing C24:0. HeLa cells exposed to an acyl-CoA mixture (16 -28: 0-CoA) strongly synthesized Cers with cerotoyl (26:0) and montanoyl CoA (28:0) ( 25% of total Cers) only upon induction of the transfected human and murine CerS3. The absolute cerotoyl-Cer amount was increased by 6-fold, while montanoyl Cer was increased at least 16-fold in case of hCerS3. With shorter acyl-CoAs, no increased incorporation was observed in the presence of CerS3. Cells overexpressing CerS2 or EGFP did not generate significant amounts of ULC-Cers (Fig. 1B-E) .
The preference of CerS3 and the inability of CerS2 to accept ULC-acyl donors were confirmed in Saccharomyces cerevisiae synthesizing montanoyl CoA upon transformation with a mutant elongase protein (Sur4p * ) (14) . The Cer-anchor pattern of the downstream product inositolphosphorylceramide (IPC) was analysed in strains in which the yeast homologues, LAG1 and LAC1, were exchanged for CerS2 or CerS3 under control of a yeast promoter. Montanoyl CoA was incorporated into IPC in the CerS3 strain, but not in the CerS2 strain confirming that montanoyl CoA is a bona fide substrate of CerS3. In addition, CerS3 accepted stearyl CoA (C18:0), lignoceroyl CoA (C24:0) and cerotoyl CoA (26:0) ( Fig. 1F and G).
CerS2 is not involved in ULC-ceramide synthesis in vivo
Although CerS2 was excluded for ULC-Cer synthesis in vitro, its mRNA level was high in murine skin (Supplementary Material, Fig. S1A ). However, CerS2 gt/gt mice show no obvious skin phenotype and similar levels of epidermal Cer species, not even for Cer containing a lignoceroyl residue (24:0), the preferred product of CerS2 (Supplementary Material, Fig. S1B -C). Our results point to an indispensable role of CerS3 and exclude CerS2 from VLC/ULC Cer synthesis in epidermis.
CerS3 deficiency in mice leads to WPB disruption and neonatal death
To gain insight into the function of CerS3 in vivo, we generated mice with a disrupted Cers3 gene. Phenotypically, CerS3 d/d mice were easily distinguished from CerS3 +/d and CerS3
+/+ mice, as their skin appeared unwrinkled, erythematous and sticky ( Fig. 2A) . Milk in the stomach of newborns (Fig. 2B ) was only observed in controls consistent with the observation that the mother rejected mutant siblings. They died Human Molecular Genetics, 2012, Vol. 21, No. 3 589 within 3 -4 h after birth and/or were devoured by the mother. It is reported that normal newborns which are not fed survive at least three times longer (12 -24 h) than observed for CerS3 mutants excluding malnutrition as a cause for their neonatal death (15) . As the erythematous appearance suggested a compromised epidermal barrier, permeability assays were carried out. Mutants exhibited a strong dye penetration, indicating barrier impairment at birth and at embryonic stage (E18.5). The WPB is normally established between E17.5 and E18.5 (16) and indeed E18.5 controls were resistant to dye penetration ( Fig. 2B and C) . The permeability defect was corroborated by over 2-fold increased TEWL rates (Fig. 2D) . As no differences in wet or dry body weight of E18.5 mutant and control embryos were found ( Fig. 2F and Supplementary Material, Fig. S2F ), the 30% decrease in body wet weight of newborn mutants (Fig. 2E ) resulted obviously from desiccation. Keeping these data in mind, all studies were carried out in newborns directly after birth.
CerS3 localizes to upper stratum spinosum (SS) and SG
In order to confirm the loss of CerS3 in mutant skin at the protein level, we determined the epidermal localization of CerS3-dependent Cer synthesis. CerS3 clustered in scattered dots within keratinocytes of upper SS and SG. In contrast, CerS3 expression was not detected in mutants ( Fig. 2G and G ′ ), thereby indicating that deletion of exon 7 renders synthesis or stability of mutated CerS3 dysfunctional.
Epidermal maturation arrests at embryonic pre-barrier stage
To find out the cause of skin stickiness, mutant epidermal structure was analyzed after embedding skin in agar before sample processing. This approach provided an intact periderm on top of mutant SC. This protective embryonic cell layer, which is normally degraded in parallel to barrier formation, failed to shed in CerS3-depleted epidermis at E18.5 and P0 (Fig. 2H-I ′ , Supplementary Material, Figs S2I -J ′ and S5A ′ ). Below the periderm, mutant SC was almost twice as thick with 40% more corneocyte layers constituting only a stratum compactum, but lacking a stratum disjunctum ( 
Antimicrobial barrier is disturbed
Increased TEWL values and reduced epidermal Cer levels are, for example, described in patients with atopic dermatitis, highly susceptible for pathogen infection (4) . Therefore, we tested whether the skin barrier of CerS3 d/d mice was also prone to infections. As a model, we inoculated cultured skin samples of newborns with C. albicans, a common opportunistic pathogen colonizing the epidermis of patients with compromised skin integrity.
In contrast to controls, prominent pathogen adhesion to mutant SC was visible as early as 6 h after inoculation. As a result, focal proliferation of C. albicans and deep invasive infection into all epidermal layers was observed after 24 h (Fig. 3A-B ′ ). At 66 h, increased colony formation occurred within lower epidermal layers, and additionally pseudohyphae that crossed the residual basement membrane migrated deep into the dermis which was marked by abundant immune cells (Fig. 3C ′ ). This enhanced fungal attack was confirmed in E18.5 mutant embryos by the determination of the colony forming units (Supplementary Material, Fig. S2O ).
Besides sphingosines, specific antimicrobial peptides are involved in cutaneous defense mechanisms against pathogens. These peptides are generally packed in LBs and extruded at the SG -SC interface (17, 18) . In mutant skin, a downregulation of antimicrobial peptide synthesis at the transcriptional level was not observed for b-defensins and cathelicidin (Supplementary Material, Fig. S2P ), suggesting a direct inhibitory effect of sphingosine on Candida growth and invasion.
ULC ceramides are absent
We used thin layer chromatography (TLC) and quantitative mass spectrometry (MS) to evaluate the effects of CerS3 depletion on the epidermal lipid composition. TLC revealed that all Cer and GlcCer bands except the correspondingly lowest band were strongly reduced or absent in CerS3 Fig. S5A ′ ) often located at tricellular contact sites. Surprisingly, in the lower SC interstices and the interface, areas with ELL were observed in mutants (Fig. 4I 1 -3 ′ and J ′ ). ELL appeared similar, independent of the postfixation method used (Fig. 4I 1 -2 and J 1 -2 , compare with mature LBs in Supplementary Material, Fig. S3C 1 -3 ). These ELL alternated with ELL-free areas (Fig. 4H ′ and I 3 ′ ) suggesting insufficient lipid secretion by LBs at the mutant interface. Indeed, the latter appeared flattened, whereas in controls the interface was marked by deep invaginations filled with lamellar stacks reflecting abundant exocytosis ( Fig. 4H and I 1, ) . As a consequence, in mutant SC, the trilaminar plasma membrane structure of 8 nm in width persisted not only at the interface (Fig. 4I 3 ′ ), but also in the upper layers of SC ( Fig. 4G ′ and Supplementary Material, Fig.  S5B ′ and C ′ ), including the outermost corneocyte layer (Fig. 6F 1 ′ ). Thus, the loss of ULC-Cers leads to impaired CLE and pore-like, ELL-free SC interstices responsible for enhanced TEWL.
Biogenesis and extrusion of LBs are accelerated
We next asked whether reduced secretion resulted from deficient intracellular LB formation. Besides lipids, lysosomerelated LBs secrete lipases and proteases such as kallikrein 5 (Klk5) and cathepsin D (Ctsd) (19) . Ctsd was used to trace LB distribution.
In controls, Ctsd labeled with high intensity the secretory front at the SG -SC interface and the sub-adjacent, uppermost Fig. 5A and A ′ ), although prepro-Ctsd processing (unpublished data) and overall mature protein levels, similar to Klk5, were not altered (Fig. 7F) . Fine structural analysis confirmed that in controls the greatest amount of LB exocytosis was found at the interface and unreleased LBs peaked at the apical surface of the second uppermost SG keratinocytes. In mutants, however, LB extrusion was limited at the interface and the highest number of unreleased LBs was detected within the third/fourth SG layer (Fig. 5D-E ′ ), indicating both premature LB formation and accelerated LB release. The quantity of LBs seemed similar in mutants ( Fig. 5E and E ′ ), whereas the diameter of LBs was slightly decreased and enclosed lamellar stacks were often shortened and fragmented ( Fig. 5E and E ′ , insets). Abundant tubular -vesicular structures with similar dimensions as LBs were observed even within the uppermost SG, but were not altered ultrastructurally in mutants. To verify that these structures were not related to LBs, but represent peroxisomes, we tracked them using the peroxisomal membrane-anchored protein Pex14, a key component of the peroxisomal import machinery (20) and diaminobenzidine (DAB) for EM visualization of catalase. Abundance and shape of peroxisomes were confirmed by DAB (Fig. 5C TEM for control). Pex14 staining revealed similar peroxisome density, but the peroxisome signal remarkably declined in mutant SG (Fig. 5C and C ′ ). The proximity of LBs and peroxisomes in SG as well as a likely decreased peroxisomal import activity in mutants hints to a potential involvement of peroxisomes in vh-Cer biosynthesis which remains to be clarified.
Non-peripheral CDs are preserved
A key question remained: how does CerS3 deficiency cause an arrest in SC maturation leading to cohesion of uppermost corneocytes and periderm? CDs as intercellular junctions are crucial in SC cohesion and proteases including Ctsd are required for their degradation (21) . In the outer layers (stratum disjunctum), non-peripheral CDs are degraded leading to the typical 'basket-weave' appearance of control skin (Figs 2H and 3A -C). Both cohesion and degradation are controlled by pH, which decreases in the upper SC (22) . . In controls, nonperipheral CDs were restricted to stratum compactum and were lacking between uppermost SC layers (Fig. 6F) ′ and F ′ 4 ). In controls, TJs were restricted to SS/SG, forming in the upper SG continuous linear structures (zonulae occludentes) which essentially contribute to the WPB ( Fig. 6D ) (24) . Although no differences were observed for claudin-1 (Figs 6C and C ′ and 7F), slightly thickened and curled strands were observed in mutant SG when labeled with cingulin, a TJ-associated protein (Fig. 6D ′ ). Thus, TJs appeared functional and are not the cause of WPB disruption in CerS3 d/d mice.
Keratinocyte cornification is delayed
The transition of SG keratinocytes to corneocytes is precisely controlled accompanied by conspicuous morphological changes, including formation of a condensed cytokeratin filament network and CE parallel to degradation of nuclei, organelles and plasma membrane. To assess whether the final cornification arrest is triggered by a delay of earlier maturation steps, we analyzed the keratohyalin granule (KG) Figs 5D and D ′ and 7E and E ′ ). However, (pro)filaggrin labeling, which normally fades with cornification, was equally distributed within the entire mutant SC (Fig. 7A and A ′ ). Along with cornification, profilaggrin is proteolytically processed in its filaggrin units which function in keratin filament compaction. It is further degraded into free amino acids to moisturize SC (25) . In mutant skin, this processing was quite insufficient as less monomeric, but much more trimeric and dimeric filaggrin units were present when compared with controls ( Fig. 7F) .
In line with a delay in cornification, the following observations were made: (i) F-actin persisted in the lower SC layers ( Fig. 6B and B ′ ), (ii) remnant nuclear material was detected in the first corneocyte layers after hemalaun, terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) (Supplementary Material, Fig. S4A ′ and B ′ ) and 4 ′ ,6-diamidino-2-phenylindole (DAPI) staining (Fig. 7D ′ ), (iii) these lower SC layers exhibited residual glycogen (Supplementary Material, Fig. S4C ′ ), restricted to viable layers in controls, and (iv) degradation of organelle structures within the first three SC layers was regularly incomplete in mutants (Supplementary Material, Fig. S4D ′ ).
Late steps in CE assembly are impaired
Sequential CE assembly results in the formation of a highly insoluble, protective layer of proteins cross-linked to the keratin filament -filaggrin complex. Whereas involucrin and transglutaminase 1 expression mark early steps in CE assembly, one of the major CE proteins, loricrin, refers to late scaffold formation (26) . To test whether CerS3 deficiency influences the expression pattern of early and/or late markers of CE assembly, we analyzed involucrin and loricrin localization by immunolabeling. Involucrin appeared only slightly delayed in mutant SG ( Fig. 7B and B ′ ) and its total protein levels were not altered 
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( Fig. 7F ). Considering the published covalent interactions of Cers with involucrin (27), we performed in situ methanolic mild alkaline treatment, but still did not visualize involucrin in the CE. Besides crosslinking CE proteins, membraneanchored Tmg1 may esterify the latter, e.g. involucrin, with vh-Cers. However, neither Tmg1 protein levels ( Fig. 7F ) nor transglutaminase activity in situ ( Fig. 5B and B ′ ) was altered. At the EM level, loricrin granules distributed around the periphery of F-granules and within nuclei of granular keratinocytes. In mutants, their number and size were markedly reduced in both compartments ( Fig. 7E and E ′ ). These observations were confirmed by WB (Fig. 7F) and immunolabeling. Strikingly different, an intense loricrin staining was observed throughout mutant SC distinctly delineating CE (Fig. 7C and C ′ ). We hypothesized that vh-Cers esterify to loricrin in control SC to cover the epitope recognized by the antibody. If so, mild alkaline treatment hydrolyzing ester bonds should release the epitope in controls for detection of loricrin. Indeed, loricrin was observed under these conditions in controls in all SC layers and in particular in the SG nuclear compartment ( Fig. 7D and D ′ ). Hence, CerS3 deficiency impaired late steps in CE assembly.
We summarized the phenotypic alterations in mutant epidermis and propose a sequence of events in Figure 8 .
DISCUSSION
Investigating the recently discovered mammalian CerS family, we addressed whether a specific CerS is required for biosynthesis of Cers with ULC-FAs, to which epidermal vh-Cers belong. Exclusively, CerS2 and CerS3 have been reported to prefer the longest acyl-CoAs (≤C26) tested in cell lysates (11, 28) . Using transfected HeLa cells and mutant yeast strains, we provide evidence that CerS3 is the only mammalian CerS capable of converting ULC-acyl-CoAs into Cers. In addition, CerS3 uses VLC-and LC-acyl-CoAs, reflecting its wide substrate specificity. Hence, a combination of CerS3 with a special acyl-CoA pool is required to explain the unique epidermal Cer pattern observed.
To assess the consequences of CerS3 dysfunction on epidermal barrier properties and structure, we eliminated exon 7 in mice which contains the first conserved amino acids of the catalytic LAG domain (29) . More importantly, exon 7 codes by computational prediction for a complete transmembrane domain. Thus, the remaining protein, if expressed, would have altered membrane topology. This systemic mutation resulted in complete loss of Cer-based SLs having acyl moieties of 26 or more carbon atoms in epidermis verifying absence of CerS3 activity and confirming in vivo that CerS3, but no other CerS, is required for ULC-Cer synthesis. SL deficiency includes those with non-, a-or v-hydroxy-acyl moieties with or without double bonds from D 15 -position onwards, pointing out a quite non-specific recognition related to acyl-CoA modifications. Furthermore, SLs with C22/24-acyl moieties are significantly reduced, validating in mice CerS3 substrate promiscuity as for acyl-CoA length. As VLC-acyl-CoAs with C22-C26 are preferred substrates of CerS2, absence of C26 and reduced C22/C24-SLs in CerS3-deficient epidermis suggest lack of CerS2 expression in Human (33 -36) . Although not mentioned, published photos of Elov4-, Cgi-58-and ABCA12-deficient mice suggest also absence of feeding in these strains (37 -39) . It may be questioned if neonatal skin barrier disruption generally alters odor signals responsible for maternal recognition and nursing (40 -42) . Using cultured neonatal skin inoculated with C. albicans, we demonstrated that the loss of VLC/ULC-SL compromises the cutaneous barrier against pathogens. Rather than altered antimicrobial peptides, the following factors may facilitate C. albicans invasion: (i) increased water flux across the deficient WPB enhancing SC hydration, (ii) impaired keratin filament compaction through insufficient filaggrin processing likely accelerating proteolysis for penetration, (iii) residual periderm improving adhesiveness, and (iv) loss of Cer downstream products per se possessing potent antimicrobial properties. Indeed, the bioactive SLs, sphingosine and phytosphingosine generated from Cers during final cornification are natural antimicrobial agents, preventing Staphylococcus aureus infection or growth of C. albicans (4,5,7). In CerS3-deficient epidermis, Cers are basically absent and sphingosine levels drop to very low levels. Our data underscore a dual, indispensable function of Cers in skin. They serve as mortar in WPB maintenance and as a superficial coat for anti-microbial defense, the latter via sphingosine.
The structural basis for barrier disruption can be clearly attributed to the presence of ELL-free intercellular domains already occurring at the interface and throughout SC. Thus, sealing of the extracellular space is strikingly insufficient and ELL-free domains may operate like pores of a sieve mediating excess paracellular water and electrolyte loss, thereby disrupting the highly regulated pH and/or Ca 2+ gradient across SC. It may be noted that ULC-Cers, completely missing in mutants, apparently are not a prerequisite of ELL formation, although the ordered structures are restricted to specific domains between the lower two to three SC layers. However, in upper SC the residual, incomplete lipid mixture, basically composed of cholesterol and free FAs, is compacted to focal agglomerates indicating impaired CLE formation. One could speculate that the absence of protein-bound Cers at the CE surface is the driving force of lipid cluster formation. Increased hydrophilic surface properties of opposing corneocytes due to insufficient CLE formation may favor their approximation pushing remaining extracellular lipids to fuse into agglomerates. Hence, an intact CLE would serve as 'chaperone' for even spreading of ELL and/or as cohesion/stabilizer of ELL. Our findings underscore the essential role of VLC/ULC-Cers in proper CLE formation required for organization and maturation of the extracellular lipid system. Consequently, a decrease in the total Cer content necessarily results in diminished barrier function as seen in many human skin disorders (2, (43) (44) (45) .
Although protein-bound vh-Cers were missing in mutants, an electron-dense CE beneath the plasma membrane appears unaltered ultrastructurally. Following the labeling of loricrin, a major CE compound comprising up to 85% of the CE proteins (46), we document loss of ULC-Cers to be responsible for unmasking of loricrin throughout the mutant SC. Like involucrin, loricrin is not recognized within control SC by most antibodies due to posttranslational processing (47, 48) . As we could release the hidden loricrin epitope in control CE upon alkaline treatment, but did not uncover involucrin, it appears plausible that the epitope recognized in loricrin is an esterification site for vh-Cers but not for other CE proteins. This suggests an important role in CLE formation for loricrin, a late component in CE assembly. It offers a suitable tool to unveil abnormalities of the cutaneous extracellular lipid system on sections from patients with skin disorders.
Unravelling the effects of vh-Cer deficiency on epidermal morphology in more detail, we demonstrate further conspicuous phenotypic alterations including accelerated LB formation and release, hyperkeratosis, abnormal SC cohesion, maintenance of the trilaminar plasma membrane structure of corneocytes and persistent periderm, all of which reflect impaired cornification.
Regarding the LB secretory system in mutants, we documented a conspicuous shift of the LB front one to two cell layers earlier which may result from increased water flux. The latter destroys the epidermal calcium gradient triggering accelerated LB synthesis and extrusion (17) . This in turn leads apparently to incomplete packing of other target components, such as Ctsd which exhibits a drastic decrease in SG labeling intensity and is nearly absent in SC.
Although LB formation and secretion appear accelerated, we observed a general maturation delay of corneocytes. In line with this delay, profilaggrin-containing KGs display a small, immature size even in the uppermost SG layer and processing of profilaggrin into monomers is retarded as residual monomers/multimers are easily recognizable in mutant SC. Before being proteolytically degraded into individual amino acids, profilaggrin is cleaved into filaggrin monomers. They crosslink keratin filaments to each other and to the CE, a process required for keratin filament bundling and compaction (25) . Lower monomer levels thus will hinder condensation of corneocytes as observed throughout mutant SC.
A processing defect of profilaggrin into filaggrin monomers has been described in mice and humans with mutations in the filaggrin gene being associated, i.e. with atopic dermatitis (49) . Here, we show delayed filaggrin processing may not necessarily result from filaggrin gene mutations, but may derive from lipid barrier abnormalities.
Further evidence for deficient cornification is reflected by persistence of corneocyte trilaminar plasma membrane structures and non-peripheral CDs. The latter are not only seen in stratum compactum like in controls, but up to the top of mutant SC, and hinder transition of stratum compactum into stratum disjunctum. Although plaque proteins, e.g. desmoplakin 1/2 likely, are degraded in control and mutant SC, the cytosolic domain of desmoglein 1 is preserved throughout mutant, but not control SC. This is in line with deficient extracellular processing of the desmosomal core containing the extracellular domains of desmoglein 1. CD retention may be (21) and requires an acidic pH for optimal activity (50). Skin hydration directly regulates SC pH. Disruption of the WPB leads to increased release of interstitial fluid with a neutral pH counteracting acidification of the skin. Additionally, the increased pH may be attributed to decreased histidine-tourocanic-acid generation as a matter of insufficient filaggrin breakdown (22) and/or dysfunction of secretory phospholipase A2 generating free FAs as well as decreased activity of the sodium-proton exchanger, type 1 (NHE1) (51) . Increased SC pH in turn may also contribute to a residual phospholipid bilayer due to lowered lipase activities. Interestingly, CD persistence is also a characteristic feature of ichthyosis and xerosis combined with hyperkeratosis (52) . Cohesive CDs may also be responsible for postnatal persistence of periderm and maintenance of its intercellular junctions (desmosomes and TJs). This embryonic structure shed before birth in controls is very sensitive to mechanical stress and therefore easily detached, leaving traces of cell debris. Indeed, residual nuclear DNA on top of SC is described in Abca12-deficient mice, but discussed as parakeratosis (53) . However, nuclear staining within SC is not detectable. These topical nuclear remnants may derive alternatively from residual periderm. It is questionable whether a persisting, but not recognized periderm exists in published mouse models presenting similar barrier defect and morphological phenotype, e.g. as documented for Elovl4-deficient mice in Figure 4B (54).
In conclusion, CerS3 is essential for the synthesis of CLEand ELL-Cers and importantly for Cer-derived sphingosines. Hence, CerS3 determines the quality of WPB and antimicrobial function as well as final cornification. Currently, no monogenetic human skin disease associated with CERS3 has been identified. As mutations may lead to impaired barrier function irreplaceable by other CerS, the phenotype expected may be related to atopic dermatitis, ichthyosis or psoriasis. Paradigmatically, in a large cohort of families affected by autosomal recessive congenital ichthyosis, 78% of all cases could be linked to established gene mutations, i.e. in FLG, ABCA12 or TGM1. For 22%, the affected gene remained to be identified. Interestingly, mutations in 12 of at least 34 genes directly affect lipid metabolism (55) . In addition, considering sphingosine as an important component of the antimicrobial barrier and innate skin immunity, i.e. chronic mucocutaneous candidiasis disease, for which in most cases the underlying etiology is still unknown (56, 57) , offers a potential linkage to the CERS3 gene. As CMC represents a prominent feature in severe atopic dermatitis (58) associated with 2-fold reduction in SC sphingosines (4) screening for mutations of CERS3 in affected families may be considered. Finally, the important role of SLs in atopic dermatitis had been underlined by the beneficial topical application of a ceramide-dominant mixture as exemplified in reference (59) , which independently of the utilized ceramide species should release antimicrobial sphingosine.
MATERIALS AND METHODS
Generation of CerS3 and CerS2 expression plasmids
Mammalian expression plasmids encoding for either human CerS2 or mouse CerS3 were generated by cloning of Cers2 (officially longevity assurance homolog 2, Lass2) or Cers3 (Lass3) cDNA into the N-terminus of an EGFP taq vector. Thus, cDNA isolated from the kidney (for CerS2) and testis (for CerS3) was amplified by PCR using specific primers (see Table 1 for primer sequences and temperature conditions). For CerS3, a DNA fragment including exons 2 -11 but excluding exon 1, which is absent in the human protein, was used for cloning. The amplified DNA fragments were then inserted into pEGFP-N1 (Clonetech) vector by HindIII/ EcoRI or EcoRI/BamHI sites for CerS2 and CerS3, respectively. Following DNA digestion of the corresponding inserts and vectors, these were subsequently ligated to generate hCerS2-EGFP and mCerS3-EGFP. For retroviral transduction, mCerS3-EGFP and human CerS3 plasmids (EX-T7111-M02, Genecopoeia) were further subcloned into pRevTRE2-EGFP. Both genes were inserted using primers flanked with BamHI and AgeI sites.
All PCR products were generated using Pfu polymerase (Promega). The sequences of all constructs were verified by DNA sequencing.
Generation of stable cell lines expressing CerS3
Stable cell lines expressing CerS3-EGFP (mouse and human), as well as EGFP (control), were generated by retroviral transduction using genetically modified HeLa cells (HeLa mCAT1-rtTA2-M2 ). Previous integration of mCAT1 (murine cationic amino acid transporter 1) and the doxycycline-sensitive transactivator rtTA2-M2 (optimized reverse tetracycline-controlled transactivator) allowed the generation of inducible HeLa cells expressing the gene of interest, as already described (60) . Briefly, viral particles required for transduction were produced in the capsid-forming cell line HEK-293T. These virions were generated via the triple transfection with (i) a MoMLV (Moloney murine leukemia virus) derived retroviral vector encoding CerS3 from the doxycycline/transactivator responsive element (pRevTRE2-CerS3-EGFP or control pRevTRE2-EGFP), together with (ii) gag-pol (pVPack-GP) and (iii) envelope (pVPack-Eco). The latter vectors are both responsible for the formation of viral proteins. MBS mammalian transfection kit and pVPack vectors were used according to the manufacturer's recommendations (Stratagene). Following 48 h transfection, virions were collected and used to transduce target cells. After 40 h incubation with 2 mg/ml doxycycline, fluorescent-positive cells were isolated by fluorescence-activated cell sorting. These populations were cultured for 7 days in the absence of doxycycline and then selected for negative fluorescence signals. Following an additional 7 days induction with doxycyline, single cell clones were sorted by EGFP-derived fluorescence. HeLa cell lines expressing mCerS3-EGFP, hCerS3-EGFP and control EGFP were generated according to this procedure.
Chemical synthesis
Montanoyl(C28:0)-CoA. For activation of the carboxylic acid, montanic acid (28:0, 100 mmol, Sigma) was dissolved in tetrahydrofuran (4 ml, Fluka). Equimolar amounts of N-hydroxysuccinimide (Fluka) and dicyclohexylcarbodiimide (Fluka) were added at room temperature (RT) and the reaction was kept under nitrogen for 12 h. The activated FAs were coupled to the polysilylated form of coenzyme A, which was generated in situ as previously described with slight modifications (61) . Thus, the trilithium salt of coenzyme A (American Radiolabeled Chemicals) was passed through a Dowex-50 ion exchange column acidified with 1 M HCl and subsequently lyophilized. The resulting free CoA (26 mmol) was dissolved in dry acetonitrile (2 ml, Fluka). Dimethylketene methyl trimethylsilyl acetal (650 mmol, Sigma) was added and the resulting solution was stirred for 16 h under nitrogen. After removal of all volatiles using a nitrogen stream, the polysilylated coenzyme A was dissolved in 1 ml of dry tetrahydrofuran. To a stirred solution of activated FA (39 mmol) in tetrahydrofuran containing CsF (1.3 mmol, Fluka) and dicyclohexano-18-crown-6 (0.13 mmol, Fluka), the coenzyme A solution was added drop-wise and the reaction mixture was stirred for 4 h at RT. The crude mixture was acidified with an equal volume of 10 mM KH 2 PO 4 (pH 5.5), and the organic solvent was removed using a nitrogen stream. The aqueous phase was desalted using a reverse phase C18 column and the final product was eluted with methanol. For quantification, MS analyses with acyl-CoAs of known concentrations were performed.
Ceramide internal standards for electrospray-ionization tandem-MS. FAs were activated into their respective N-hydroxysuccinimide esters as reported above, and then condensed (40 mmol each) with d17:1-sphingosine (10.5 mmol, Avanti Polar Lipids) in a final volume of 4 ml tetrahydrofuran. The reaction was catalyzed by triethylamine (Sigma) for 1 -2 days at RT in an inert atmosphere. The crude products were purified by silica gel flash-column chromatography using mixtures of hexane/isopropanol/water of increased polarity as solvent system. For quantification, a dilution series of the purified products were spotted on a high-performance TLC (HPTLC) together with standards of known concentration and separated with the cloroform/methanol/acetic acid (188/ 11/1). After development with 10% copper (II) sulphate in 8% sulphuric acid (10 min at 1808C), quantification of the bands was performed by densitrometric scanning using a TLC scanner (Shimadzu CS-9301).
ULC-CoA specificity assay of CerS2 and CerS3
Living mammalian cells. HeLa cells stably transfected with mouse and human CerS3, EGFP control, as well as untreated cells (HeLa mCAT1-rtTA2-M2 ) were seeded onto six-well plates with a density of 1 × 10 5 cells/well with or without induction with 2 mg/ml doxycycline. Forty-eight hours after seeding, untreated cells were transfected with hCerS2-EGFP and incubated for 4 h at 378C. The assay was started by exposing the cells to media containing a mixture of saturated acyl-CoAs, namely C16:0, C18:0, C24:0, C26:0 (Avanti Polar Lipids) and C28:0 (10 mM each) and 6 mM sphingosine (d17:1). Upon 20 h of reaction, cells were harvested and lipids extracted. Uptake only occurred in the presence of the crude montanoyl CoA (as described), with no incorporation using HPLC-MS purified C28:0-CoA.
Yeast. The strains used for this assay were the following: RH2888 (MATa his3 leu2 lys2 trp1 ura3 can1 bar1), RH6974 (MATa FLAG-MmCerS2::TRP1 lac1D::ADE2 lag1D::HIS3 leu2 ura3 lys2 can1 bar1) and RH6975 (MATa FLAG-HsCerS3::TRP1 lac1D::ADE2 lag1D::HIS3 leu2 ura3 lys2 can1 bar1). All mutations were constructed using standard gene disruption procedures, with complete removal of open reading frames in the RH2888 strain background. Double and triple mutants were obtained by genetic crosses. Synthetic N-terminally FLAG-tagged (FLAG-tag sequence: N-DYKDDDDK-C) open reading frames corresponding to mouse CerS2 and human CerS3 were purchased from (14) . Yeast was grown on SD medium with the required nutrients to a final concentration of 1 OD 600 /ml and lipids were extracted from 50 ml of cells as described below.
Generation of CerS3 d/d mice
The Cers3 gene (ceramide synthase 3, Lass3, NCBI gene ID: 545975) was found in a mouse C57Bl6 bacterial artificial chromosome (BAC) Library (RPCI-23 No. 731, German Resource Center for Genome Research, RZPD). From the corresponding BAC-DNA clone, a 10 kb XbaI/XhoI fragment including exons 5 -9 of Cers3 was subcloned into a pBluescript plasmid vector (Stratagene). An HSVtk-PGKneo cassette flanked by two FRT, one 5 ′ -single loxP side and a diagnostic SacI side was cloned into ClaI in introns 6 -7. A single loxP site was inserted into SpeI of introns 7 -8. A PGK-DTA cassette was inserted into XhoI at the 3 ′ end of the targeting construct. E14 ES cells derived from mouse strain 129 SV Ola were transfected in the presence of the linearized Cers3-targeting vector. Stem cell clones were picked, expanded and checked for homologous recombination of Cers3 by Southern blot analysis. Genomic ES-cell DNA was digested with SacI and a digoxigenin labeled 3 ′ -outside probe (Roche) was used to stain wild-type and mutant alleles. No positive clone could be detected out of 384 cultivated. Sequence analysis of the C57Bl6 mouse line-derived targeting vector DNA resulted into pronounced variations in particular within intron 5 of the 5 ′ region of the targeting construct when compared with 129 SV Ola DNA from which mouse strain stem cells were derived. Therefore, the 5 ′ arm of the targeting construct was replaced by a PCR product amplified with a proofreading polymerase from a genomic 129 SV Ola DNA. Sequence analysis of the changed targeting construct showed a correct Cers3 sequence for all exons, including the 129 SV Ola derived 5 ′ -arm. As verified by Southern blot analysis, electroporation with the reconstructed vector resulted in two clones out of 384 with correct 5 ′ insertion of the targeting construct, including the selection cassette with 5 ′ loxP side. Only one of the respective ES clones showed an integration of the single loxP site 3
′ from exon 7. Stem cells from the latter clone were expanded and injected into blastocysts. Germline transmission of mutant stem cells was achieved, indicated by agouti colored offspring from chimeras. F1 offspring with loxP-flanked exon 7 were further mated with cre-deleter mice to obtain a systemic deletion of exon 7 of the Cers3 gene. In the next breeding step, the cre-transgene was again removed by mating with C57Bl6 wild-type mice. Heterozygous mice were mated in order to generate homozygous offspring with complete exon 7 deletion in Cers3 in both alleles.
All animal procedures were approved and performed in accordance with federal laws (Regierungspräsidium Karlsruhe, Germany, G-68/07, G-8/07 and A-62/06).
Genotyping of mutant mice
ES cells, F1 offspring and mutant mice were genotyped by Southern blot and PCR analyses. The 3 ′ and 5 ′ Southern probes were synthesized using the PCR DIG probe synthesis kit, essentially according to the manufacturers protocol (Roche). For PCR analyses, either genomic DNA isolated from mice tails or cDNA isolated from skin were used as templates to amplify specific products for wild-type and mutant alleles. Primers used to perform these analyses including the corresponding conditions are specified in Table 2 . The generation of the truncated Cers3 transcript lacking exon 7 in mutant mice was confirmed by DNA sequencing.
RNA isolation and quantitative real-time PCR
Neonatal CerS3
d/d and littermate control skin was collected to compare relative mRNA expression levels of CerS Human
homologues and antimicrobial peptides. Total RNA was extracted using Trizol reagent (Invitrogen) according to the manufacturer's instructions, following integrity assessment using RNA6000 Nanochip (Agilent). Double-stranded cDNA was synthesized and evaluated for relative gene expression as previously described (13) . Results represent the fold-change of expression calculated using the comparative C t method. Normalized DC t values were compared with normalized DC t of wild-type mCers5-and mCamp-mRNA for quantification of Cers-and antimicrobial peptide-mRNAs, respectively. Primers used for enhancing specifically each Cers homologue were as reported (13), with the exception of Cers3, where primers within exons 7 and 8 were used and are indicated in Table 2 . Primers used for quantitative reverse transcription polymerase chain reaction (qRT -PCR) of antimicrobial peptides and the corresponding specific conditions are detailed in Table 3 .
Skin permeability assay
Skin permeability was tested by diffusion using Mayer's hemalaun essentially as described (38) . In brief, euthanized embryos and newborn animals were fixed in methanol for 5 min, washed with phosphate-buffered saline (PBS) and incubated in Mayer's hemalaun (Roth) for 20 -30 min at RT. Excess hemalaun was removed by several thorough washes with PBS. After hemalaun staining, images of the animals were captured using a digital camera.
Determination of TEWL and epidermal pH
TEWL was measured using a Tewameter TM300 (CourageKhazaka Electronics) as described (48) . Preliminary skin surface pH measurements were performed using humidified pH-indicator strips (pH 5.2-7.2, Merck).
Candida albicans infection of cultured skin samples
Interscapular skin samples of newborns were maintained viable on collagen gels partially submerged in the Dulbecco's modified Eagle's medium (DMEM) (Lonza, BE12-604F) supplemented with 50 U/ml penicillin and 50 mg/ml streptomycin (Gibco). Collagen gels were prepared as previously described (62) . Thus, type I collagen was isolated from tail tendons of young rats and lyophilized. To a 4 mg/ml solution of collagen in 0.1% acetic acid was added 10% of 10× Hank's balanced salt solution (Gibco) titrated with 5 M sodium hydroxide and 10% of the DMEM medium. The mixture was allowed to jellify in PET membrane filter inserts (Falcon) for 1 h at 378C, following the addition of 12 ml DMEM medium in each of the deep-wells (BD Biosciences, BD 355467).
Candida albicans (ATCC 90028) grown overnight in the LB medium were harvested and resuspended in PBS to a concentration of 10 9 /ml. Candida albicans (1 × 10 6 cells, 1 ml) were inoculated to the center of the skin sample and incubated at 308C for the specified time.
For quantification of microbial growth, infected skin samples from E18.5 + 0.5 mice were flushed with 10 ml PBS. An aliquot of these suspensions (100 ml) were plated in two different dilutions on Sabouroud agar plates (bioMér-ieux). Multiple serial dilutions had been previously performed to determine optimal conditions. After 24 h incubation at 378C, colonies were counted and concentrations were determined as colony forming units (CFU/ml).
Lipid extraction
For the extraction of epidermal lipids, interscapular skin samples were rapidly dissected and snap-frozen in liquid nitrogen. To separate epidermis from dermis, samples were treated with 500 mg/ml thermolysin buffer (containing 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 142 mM NaCl, 6.7 mM KCl, 0.43 mM NaOH, 1 mM CaCl 2 at pH 7.4) for 2 h at 378C (63) . Isolated epidermis was then cut into small pieces and lyophilized. SLs were extracted according to Doering et al. with slight modifications (48, 64) . In brief, 3 mg of dry weight epidermis was extracted with 2 ml of chloroform/methanol/distilled water 30/60/8 by volume at 508C for 15 min under sonication. Supernatant was taken after centrifugation and pellets were re-extracted two additional times using the solvent mixtures of chloroform/methanol/distilled water, 10/10/1, and chloroform/ methanol, 2:1 by volume. Supernatants were pooled and desalted using reversed phase RP-18 columns. For further analysis, aliquots of the extract pool were saponified under mild alkaline conditions (0.1 M methanolic KOH, 4 h, 508C), neutralized with acetic acid and desalted using 100 mg-RP-18 columns. Protein-bound SLs were extracted from the above obtained pellets. Pellets were 'washed' three times with 2 ml of 100% methanol for 5 min and two times with 2 ml of 95% methanol at 608C for 2 h to remove residual-free lipids. Treatment of the residual pellets with 1 ml of 1 M KOH in 95% methanol at 608C for 2 h cleaved ester linkages and released protein-bound SLs. Supernatants were neutralized with acetic acid and desalted using RP-18 columns as above.
For the extraction of SLs from HeLa cells, dried cell pellets were extracted twice with 2 ml of chloroform/methanol/distilled water, 10/10/1 and once with 30/60/8 (by vol.) for 15 min at 378C. Combined lipid extracts were subjected to methanolic mild alkaline hydrolysis for 2 h at 378C, sequentially neutralized and desalted.
For the extraction of yeast lipids, internal standards were added to the samples (10 mg each of Cer (d18:1,17:0) and GlcCer (d18:1, 8:0), Avanti Polar Lipids), which were then extracted using an ethanol-ether-based solvent and base treated with monomethylamine as described (65) . Lipids were desalted with butanol and analyzed by MS.
Lipid analyses
Lipids isolated from epidermal extracts were first analyzed by TLC. Lipids corresponding to 0.5 mg dry weight were spotted on HPTLC plates (Silicagel 60 F 254 , Merck) using a Linomat IV (Camag). Afterwards, lipids were separated sequentially with the following solvent systems: (i) chloroform/acetone (1/1) for 4 cm, (ii) chloroform/methanol/glacial acetic acid (60/35/8) for 7 cm, (iii) chloroform/methanol/glacial acetic acid (190/9/1) for 12 cm, and (iv) n-hexane/methyl t-butyl ether/glacial acetic acid (90/10/1) until the top (20 cm) . In between the different solvent systems, plates were thoroughly dried under vacuum. Bands were then made visible by spraying the TLC plates in 10% copper sulphate in 8% sulphuric acid and developing at 1808C.
Quantification of SLs was performed by tandem MS (triple quadrupole instrument equipped with a nano-electrospray source, VG micromass model Quattro II, Waters) according to reference (48) . Equivalent lipid samples regarding the protein content were dissolved in 5 mM ammonium acetate in methanol. Prior to being analyzed, internal standards were added to the aliquots. Linoleic acid-esterified vh-SLs were determined by subtraction of the amount of free vh-SLs of the non-treated epidermal extracts from the respective amounts of vh-SLs evaluated after saponification.
Epidermal sphingosine levels were quantified with a novel assay based on derivation of sphingosine prior to tandem MS (unpublished data).
For the quantification of yeast extracts, lipids were introduced into a Varian 320MS triple quadrupole in LC mode by direct infusion in methanol/chloroform/water (7/2/1, containing 2 mM ammonium acetate) (66) . To quantify lipid species, multiple ion monitoring was used for each species (65) . The recoveries and amounts of different IPC species were calculated relative to the GlcCer (d18:1, 8:0) standard according to a standard curve. Results are presented as a percentage of total IPCs detected because absolute amounts could not be determined without internal standards.
Epidermal protein isolation and western blotting
Skin samples were incubated at 588C for 6 min in PBS containing 10 mM ethylenediaminetetraacetic acid (EDTA) in order to separate dermis from epidermis. Skin was then transferred into ice-cold PBS-EDTA solution and epidermis was obtained by peeling off the dermis. Epidermis in digitonin lysis buffer [20 mM HEPES-NaOH buffer (pH 7.4) containing 25 mM KCl, 250 mM sucrose, 2 mM MgCl 2 , with freshly added 1% digitonin (Sigma), complete protease inhibitors (Roche) and 0.5 mM DTT] was homogenized by sonication (Branson sonifier 250) using five pulses every 30 s for 5 min. Lysates containing epidermal proteins were cleared by centrifugation at 21 000g for 15 min. Equal amounts of protein (50 mg) were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, blotted onto nitrocellulose membranes, incubated with primary antibodies overnight at 48C and secondary antibody for 45-60 min at RT (details in Tables 4  and 5 ).
Light and electron microscopy
All morphological data included a minimum of two animals per group. Mouse embryos (E18.5) and newborns were anesthetized and transcardially perfused for 5 -10 min with 3.5 -4% glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.6) containing saturated picric acid (300 ml per 100 ml fixative solution), 2% polyvinylpyrrolidone (PVP, Polyvidon 25, MW 25000, Merck) and 0.05% CaCl 2 . Interscapular skin samples were removed and additionally postfixed overnight in the same fixative. In order to preserve the periderm and the adherent SC layers, samples were embedded in agar (Extrapure, Merck). Sections of 80-150 mm thickness were prepared using a microslicer (Dosaka DTK 1000). Sample processing followed three different procedures tested for optimal visualization of LB and ELL structure as well as keratinocyte morphology. Following the protocol of reference (67), the first series were treated with 0.25% RuO 4 (Polysciences) in 0.1 M sodium cacodylate buffer, pH 6.8 containing 0.5% potassium ferrocyanide for 15 min (Supplementary Material, Fig. S3A 1 ) . The second series was postfixed according to reference (68) with 1% buffered OsO 4 in 0.1 M sodium cacodylate buffer, pH 7.6 for 90 min, followed by treatment with 1% tannic acid (Merck) in 0.5 M sodium cacodylate buffer, pH 7.5 for 10 min. Sections were immersed in the same buffer containing 1% Na 2 SO 4 for 90 s (Supplementary Material, Fig. S3A 2 ) . As described (69), the third series was incubated 60 min in alkaline DAB for selective catalase visualization and enhancement of membrane staining. Sections were postfixed with 1.5% buffered OsO 4 in sodium cacodylate buffer, pH 7.6 containing 1.5% potassium ferrocyanide for 20-30 min, followed then by osmification without ferrocyanide for an additional 40-60 min. En bloc staining was performed with 1% uranyl acetate for 20-30 min (Supplementary Material, Fig. S3A 3 ) . Samples of all three series were washed with the respective buffers and processed for embedding in Epon 812.
Fixed on Superfrost w slides, serial semithin sections of 0.5-1 mm thickness were prepared (Leica Ultracut UCT) and stained with periodic acid-Schiff (PAS) as described (70 Light microscopical analysis of C. albicans invasion. Inoculated skin samples grown on collagen gels were fixed with 4% formalin for 24 h and subsequently embedded in paraffin. Sections (Microm, HM 355S) of 1 mm thickness were prepared, deparaffinized and stained with PAS: 0.75% periodic acid solution for 10 min, Schiff solution for 5 min. Following rinsing and drying steps, sections were counterstained with Mayer's hemalaun (Roth). Sections were dehydrated and mounted with Vitro-Clud (Langenbrink) and analyzed using a Leica DMLB microscope.
Immunohistochemistry
To guarantee optimal morphology, mice were transcardially perfused with 3 -4% paraformaldehyde (PFA) in 0.1 M PBS, pH 7.4 containing 2% PVP for 5 -10 min. Interscapular skin samples were postfixed for additional 30 -60 min at 48C and rinsed with PBS containing 2% PVP. These samples were used for paraffin sections and after embedding in agar for ultracryosemithin sections.
Paraffin sections. Specimens were dehydrated and embedded in Paraplast Plus. Sections of 3 -5 mm thickness were obtained with a Microm HM 340E, then deparaffinized and subjected to antigen retrieval with 10 mM sodium citrate and 0.5% Tween-20 (pH 6.0) for 20 min at 968C. Ctsd, desmoglein 1/ 2, desmoplakin 1/2, (pro)filaggrin, loricrin and CerS3 were detected according to this protocol.
In situ mild alkaline hydrolysis. For extraction of proteinbound SLs, paraffin sections were deparaffinized and immersed in 100% ethanol followed by 100% methanol. Mild alkaline methanolysis was performed (0.1 M KOH in 95% methanol) for 2 h at RT. Sections were carefully rinsed in methanol, immersed in 100% ethanol, dehydrated and rinsed in distilled water prior to antigen retrieval as described. Desmoglein 1/2, loricrin and involucrin were subjected to this protocol.
Ultracryosemithin sections. Microslicer sections of 600 mm thickness were cryoprotected in sucrose (10%, 20%, 30% and 2.3 M in 0.1 M PBS, pH 7.6 containing 10% PVP) prior to be frozen in isopentane precooled with liquid nitrogen. Subsequently, ultracryosemithin sections of 0.6-0.8 mm thickness were prepared with a Leica Ultracut UCT equipped with a Leica EMFCS and immunolabeled for F-actin, loricrin, desmoglein 1/2 and involucrin.
For the detection of sensitive antigens, unfixed interscapular skin samples were removed from anesthetized neonates and quickly placed onto a straight aluminum foil, immersed in OCT (Tissue Tek) and frozen in isopentane precooled with liquid nitrogen. Cryosections of 3-5 mm thickness were obtained with a Leica CM 3050S and subsequently fixed with acetone for 10 min at RT. For the detection of claudin 1, sections were subjected to an antigen retrieval as described. In order to localize cingulin and keratins 10 and 14, sections were permeabilized with 0.1% Triton X-100 in PBS (v/v) for 5 min and then blocked for 30 min with 10% fetal calf serum.
Transglutaminase 1 activity assay. Transglutaminase activity was localized as described with slight modifications (71) . Shortly, unfixed fresh skin cryosections of 3 -5 mm thickness were air-dried for 30 min and rinsed in PBS. Sections were blocked with 1% BSA in 100 mM Tris buffer (pH 7.4) for 30 min, following 1 h incubation with 12 mM monodansylcadaverine (Sigma) in 100 mM Tris buffer (pH 7.4) containing 5 mM calcium chloride. For negative controls, EDTA was added into the substrate buffer to a final concentration of 20 mM. The enzymatic reaction was stopped with 10 mM EDTA in PBS for 5 min. After rinsing in PBS, sections were incubated for 3 h with anti-dansyl in 12% BSA-PBS. Subsequently, sections were washed and incubated for 45 min with a secondary antibody in 12% BSA-PBS. Following nuclear staining, specimens were mounted and directly analyzed.
Immunolabeling. Ultracryosemithin-, cryo-and paraffin sections were incubated with primary antibodies for 1 -16 h at 48C or at RT (antibodies and the concentrations used are listed in Table 4 ). Incubation with secondary antibodies (see Table 5 ) was carried out for 1 h at RT.
For detection of nuclei and residual DNA, staining with DAPI (20 ng/ml, Sigma) or Draq5 TM (Biostatus) was performed. Sections were mounted in either Fluoromount-G or DakoCytomation fluorescent mounting medium. For negative controls, PBS was used instead of primary antibodies. Sections were visualized with the fluorescence microscope Biorevo BZ-9000 (Keyence).
Proliferation assay with Ki67. Interfollicular keratinocyte proliferation was assessed in paraffin sections of PFA fixed skin using Ki67 as a marker (DakoAutostainer). Following binding with primary antibody, sections were incubated with a biotinylated anti-rat antibody and detected with alkaline phosphatase-labeled streptavidin (Tables 4 and 5 ).
Terminal dUTP nick-end labeling. TUNEL assay was performed on unfixed skin cryosections embedded in paraffin using the in situ cell death detection kit (Roche) and the recommendations provided by the manufacturer. After staining with Mayer's hemalaun, the sections were analyzed using a Leica DM-RBE microscope.
Localization of cholesterol and neutral lipids with filipin and Nile red
Unfixed cryosections were stained with filipin (cholesterol) or with Nile red (neutral lipids) as previously reported with slight modifications (72, 73) . Sections were air-dried, rinsed, fixed in 4% phosphate-buffered formalin and stained either with freshly prepared filipin (10 mg/ml in PBS with 1% DMSO) for 2 h or with freshly prepared Nile red (5 mg/ml in 75% glycerol) for 5 min. Specimens were mounted in Fluoromount-G and analyzed (Biorevo BZ-9000, Keyence).
CerS3 localization in cultured HeLa cells
For subcellular localization of CerS3, HeLa cells were seeded and transfected with lipofectamine on sterile 12 mm glass cover slips. Following 24 h after transfection with mCerS3-EGFP plasmid, cells were washed with chilled PBS. CerS3 expressing cells were fixed with 3.5% PFA for 5 min on ice and for 10 min at RT. After permeabilization with methanol (2208C, 6 min) (74), blocking was carried out for 1 h with 3% BSA-PBS. Primary antibodies were incubated for 1.5 h and secondary antibodies for 45 min at R. Immunofluorescence images were acquired with a Leica TCS-SL microscope using Leica Confocal software (version 2.61).
Generation and purification of CerS3 antibody
A synthetic peptide located at the C-terminus of mouse CerS3 protein was generated to immunize rabbits (PickCell Laboratories). The antiserum containing the polyclonal antibody was purified by affinity chromatography using the corresponding peptide coupled to N -hydroxysuccinimide-activated sepharose. The purified antibody was eluted with a low pH glycine buffer (70 mM glycine in 0.6 mM phosphate buffer pH 2.7) and concentrated using an Amicon Ultra 15 centrifugal filter device (Millipore) at 4000g for 20 min. Protein concentration was determined to 11.6 mg/ml.
Statistical analysis
Statistical analysis was performed using Student's t-test, and differences among groups were considered significant for P , 0.05 ( * ), P , 0.01 ( * * ) and P , 0.001 ( * * * ).
